⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABCL News
AbCellera Biologics Inc. Common Shares
AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.
globenewswire.com
ABCL
HYFT
AMD
ABSI
NVDA
Microfluidics Market Size, Share, and Trends - Global Forecast 2026-2032 | AI-Enabled Diagnostics and Organ-on-Chip Platforms Propel 7.00% CAGR Toward USD 35.41 Billion
globenewswire.com
ZTS
ABCL
AGNC
BIO
DHR
ILMN
OPK
QDEL
TMO
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
globenewswire.com
TWST
ABCL
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
businesswire.com
ABCL
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
prnewswire.com
ABCL
HYFT
TEM
LLY
MU
TWST
Vasomotor Symptoms Market Poised for Growth Through 2036, Driven by Rising Adoption of Hormonal and Non-Hormonal Therapies | DelveInsight
prnewswire.com
PFE
AMPH
ASRT
ABCL
VSTA
North America Clinical Trials Market Report 2026-2034: Size, Share, Trends, and Forecast by Phase, Indication, Study Design, Country, and Company | AI Adoption Fuels 6% CAGR
globenewswire.com
CRL
IQV
ICLR
ABCL
PFE
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
globenewswire.com
ABBV
ABCL
AZN
BIIB
BMY
EXEL
GILD
GSK
INCY
LRCX
MRK
NVS
PFE
REGN
SNY
TMO
UCB
VRTX
Global Drug Discovery Market Forecast 2026-2032: AI, Precision Biology, Multi-Omics, and Advanced Modalities are Reshaping Discovery Workflows
globenewswire.com
TMO
CRL
DHR
MRK
EVTC
AVT
IQV
BRKR
ILMN
BIO
CERT
RRX
ABCL
ABSI
TWST
BNGO
Juno Industries Announces Expanded Board, Advisory and Leadership Team Ready to Announce with Confidence?
newsfilecorp.com
GS
ABCL